Skip to main content
. 2019 Oct 22;15:358. doi: 10.1186/s12917-019-2087-2

Table 3.

Clinical trial carried out with mesenchymal stem cells in canine atopic dermatitis

Specie (number) Treatment Results Conclusion Reference
Dog (5) Single IV autologous ASCs (1.3 million cells/kg) No benefits of ASCs treatment were observed. The dosage of ASCs was lower than employed in other studies. The results are inconclusive. [54]